Clinical Trial Update: Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients [NA]

View source ↗

Summary

Completed update on Abbott Medical Devices’ Trip HF Study evaluating triple resynchronization therapy in paced heart failure patients with ventricular dyssynchr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Dyssynchrony

Drugs mentioned

• Trip HF Study - Triple Resynchronization in Paced Heart Failure Patients

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure, Ventricular Dyssynchrony | NA | Status: COMPLETED